These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1755800)

  • 21. Cholesterol: precursor to many lipid disorders.
    Jones PH
    Am J Manag Care; 2001 Aug; 7(9 Suppl):S289-98. PubMed ID: 11517815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implications of changing national cholesterol education program goals for the treatment and control of hypercholesterolemia.
    Persell SD; Lloyd-Jones DM; Baker DW
    J Gen Intern Med; 2006 Feb; 21(2):171-6. PubMed ID: 16390501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV; Frick KD; Wade A; Simko R; Burge R
    Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Descriptive analysis of medical attrition in U.S. Army aviation.
    Edwards RJ; Price DR
    Aviat Space Environ Med; 1989 Jul; 60(7 Pt 2):A92-7. PubMed ID: 2775128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New guidelines for lowering blood cholesterol.
    Goodman DS
    Clin Lab Med; 1989 Mar; 9(1):17-27. PubMed ID: 2647373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults.
    Hyre AD; Muntner P; Menke A; Raggi P; He J
    Ann Epidemiol; 2007 Jul; 17(7):548-55. PubMed ID: 17395483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of the National Cholesterol Education Program and joint European treatment criteria and clinical benefit in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
    Gotto AM; Whitney E; Stein EA; Shapiro DR; Clearfield M; Weis S; Jou JY; Langendörfer A; Beere PA; Watson DJ; Downs JR; de Cani JS
    Eur Heart J; 2000 Oct; 21(19):1627-33. PubMed ID: 10988016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concentrations of low-density lipoprotein cholesterol and total cholesterol among children and adolescents in the United States.
    Ford ES; Li C; Zhao G; Mokdad AH
    Circulation; 2009 Mar; 119(8):1108-15. PubMed ID: 19221218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. U.S. Army anthropometric standards for rotary-wing aviators in the light observation helicopter.
    Farr WD; Buescher TM
    Aviat Space Environ Med; 1989 Jul; 60(7 Pt 2):A74-6. PubMed ID: 2775126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implications from the Air Force/Texas Coronary Atherosclerosis Prevention Study for the Adult Treatment Panel III guidelines.
    Clearfield M; Downs JR; Lee M; Langendorfer A; McConathy W; Gotto AM
    Am J Cardiol; 2005 Dec; 96(12):1674-80. PubMed ID: 16360356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid levels. Applying the second National Cholesterol Education Program report to geriatric medicine.
    Mormando RM
    Geriatrics; 2000 Aug; 55(8):48-53; quiz 54. PubMed ID: 10953686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A population-based treat-to-target pharmacoeconomic analysis of HMG-CoA reductase inhibitors in hypercholesterolemia.
    Hilleman DE; Phillips JO; Mohiuddin SM; Ryschon KL; Pedersen CA
    Clin Ther; 1999 Mar; 21(3):536-62. PubMed ID: 10321422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid management program: results of applying national guidelines in a private practice.
    Robbins JA; Dickinson WA; Bartel AG; Hartman CW
    South Med J; 1993 Mar; 86(3):289-92. PubMed ID: 8451666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: data from National Health and Nutrition Examination Survey 1999 to 2002.
    Keevil JG; Cullen MW; Gangnon R; McBride PE; Stein JH
    Circulation; 2007 Mar; 115(11):1363-70. PubMed ID: 17353444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of elevated serum cholesterol in personnel of the U.S. Navy.
    Trent LK
    Public Health Rep; 1991; 106(2):167-75. PubMed ID: 1902309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracorporeal LDL cholesterol removal: role of LDL-pheresis in combination with other hypolipidemic therapy to regress vascular disease.
    Saal SD; Gordon BR; Parker TS; Levine DM; Tyberg TI; Rubin AL
    Am J Med; 1989 Nov; 87(5N):68N-74N. PubMed ID: 2486551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The National Cholesterol Education Program: implications for dietetic practitioners from the Adult Treatment Panel recommendations.
    Ernst ND; Cleeman J; Mullis R; Sooter-Bochenek J; Van Horn L
    J Am Diet Assoc; 1988 Nov; 88(11):1401-8, 1411. PubMed ID: 3183260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening and treatment of hypercholesterolemia for prevention of coronary heart disease.
    Wang YR; Alexander GC; Meltzer DO
    Manag Care Interface; 2006 Jan; 19(1):25-9. PubMed ID: 16453992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.